ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
11.33
-2.26 (-16.63%)
At close: Mar 24, 2026, 4:00 PM EDT
11.50
+0.17 (1.50%)
After-hours: Mar 24, 2026, 5:26 PM EDT
ADMA Biologics Employees
As of December 31, 2025, ADMA Biologics had 647 total employees, including 640 full-time and 7 part-time employees. The number of employees decreased by 38 or -5.55% compared to the previous year.
Employees
647
Change (1Y)
-38
Growth (1Y)
-5.55%
Revenue / Employee
$788,521
Profits / Employee
$227,094
Market Cap
2.70B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 647 | -38 | -5.55% | 640 | 7 |
| Dec 31, 2024 | 685 | 61 | 9.78% | 677 | 8 |
| Dec 31, 2023 | 624 | 7 | 1.13% | 624 | 0 |
| Dec 31, 2022 | 617 | 90 | 17.08% | 617 | 0 |
| Dec 31, 2021 | 527 | 120 | 29.48% | 527 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Denali Therapeutics | 503 |
| Dyne Therapeutics | 258 |
| Alumis | 224 |
| Structure Therapeutics | 220 |
| Edgewise Therapeutics | 146 |
| Centessa Pharmaceuticals | 114 |
ADMA News
- 22 days ago - ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative - GlobeNewsWire
- 26 days ago - ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 2 months ago - ADMA Biologics: Business Update And My Price Target - Seeking Alpha
- 2 months ago - ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update - GlobeNewsWire
- 2 months ago - ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026 - GlobeNewsWire